Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Small Pharma Inc V.DMT

Small Pharma Inc. is a biotechnology company focused on short-duration psychedelic therapies for mental health conditions. The Company is focused on developing short-duration psychedelic-assisted therapies for the treatment of mental health conditions that are scalable, commercially differentiated, and conveniently dosed, with the goal of addressing key unmet needs in the treatment of depression. It has a portfolio of clinical-stage dimethyltryptamine (DMT)-based assets, SPL026 and SPL028. It has a pipeline of proprietary preclinical assets. Its clinical-stage program, SPL026, a first-generation DMT molecule, has shown proof-of-concept for the potential treatment of MDD. In a Phase IIa study, IV SPL026 demonstrated a rapid and durable antidepressant effect, as well as a favorable safety and tolerability profile. Small Pharma is also advancing SPL028, a second-generation injectable deuterated DMT molecule, in a Phase I trial.


TSXV:DMT - Post by User

Comment by GillRipperon Aug 25, 2022 5:06pm
77 Views
Post# 34921002

RE:Peter Rands buys 96,000 shares of DMT for $0.18 each

RE:Peter Rands buys 96,000 shares of DMT for $0.18 eachInsider trading activity looks good!

Managed to accumulate a few hundred thousand sheets over the past month. (.16 av)

Wonder when they'll begin dipping into the market, (share buyback).

Nice little Interview here on psychedelic therapies

https://www.medicalgold.ca/featured/exclusive-interview-with-scott-freeman-biotech-investor-and-former-cmo-of-mindmed

Dr John Campbell

https://www.youtube.com/watch?v=2LN6LJiXqWs&t=172s

Future looks bright here IMHO.

Patience required imo.

Kind Regards To All

Gilly 

August Insider trades.

Date Issuer Insider Transaction Amount New Balance
Recent filings 
Filed 2022-08-25 11:50
 
Tx date 2022-08-24
$DMT 
Small Pharma Inc. (formerly, Unilock Capital Corp.)
Rands, Peter David
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$13,500 
+75,000 vol 
$0.18 each
78,012,443  
Filed 2022-08-25 11:50
 
Tx date 2022-08-24
$DMT 
Small Pharma Inc. (formerly, Unilock Capital Corp.)
Rands, Peter David
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$1,620 
+9,000 vol 
$0.18 each
77,937,443  
Filed 2022-08-25 11:49
 
Tx date 2022-08-24
$DMT 
Small Pharma Inc. (formerly, Unilock Capital Corp.)
Rands, Peter David
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$2,160 
+12,000 vol 
$0.18 each
77,928,443  
Older filings 
Filed 2022-08-22 07:59
 
Tx date 2022-08-19
$DMT 
Small Pharma Inc. (formerly, Unilock Capital Corp.)
Rands, Peter David
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$8,748 
+54,000 vol 
$0.162 each
77,916,443  
Filed 2022-08-22 07:58
 
Tx date 2022-08-19
$DMT 
Small Pharma Inc. (formerly, Unilock Capital Corp.)
Rands, Peter David
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$3,062 
+17,500 vol 
$0.175 each
77,862,443  
Filed 2022-08-22 07:58
 
Tx date 2022-08-19
$DMT 
Small Pharma Inc. (formerly, Unilock Capital Corp.)
Rands, Peter David
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$13,725 
+75,000 vol 
$0.183 each
77,844,943  
Filed 2022-08-22 07:57
 
Tx date 2022-08-19
$DMT 
Small Pharma Inc. (formerly, Unilock Capital Corp.)
Rands, Peter David
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$3,700 
+20,000 vol 
$0.185 each
77,769,943  
Filed 2022-08-22 07:56
 
Tx date 2022-08-19
$DMT 
Small Pharma Inc. (formerly, Unilock Capital Corp.)
Rands, Peter David
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$7,520 
+40,000 vol 
$0.188 each
77,749,943  
Filed 2022-08-22 07:56
 
Tx date 2022-08-19
$DMT 
Small Pharma Inc. (formerly, Unilock Capital Corp.)
Rands, Peter David
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$7,800 
+40,000 vol 
$0.195 each
77,709,943  
Filed 2022-08-22 07:54
 
Tx date 2022-08-19
$DMT 
Small Pharma Inc. (formerly, Unilock Capital Corp.)
Rands, Peter David
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$5,700 
+30,000 vol 
$0.19 each
77,669,943  
Filed 2022-08-22 07:54
 
Tx date 2022-08-19
$DMT 
Small Pharma Inc. (formerly, Unilock Capital Corp.)
Rands, Peter David
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$2,751 
+14,110 vol 
$0.195 each
77,639,943  
Filed 2022-08-22 07:53
 
Tx date 2022-08-19
$DMT 
Small Pharma Inc. (formerly, Unilock Capital Corp.)
Rands, Peter David
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$7,117 
+36,500 vol 
$0.195 each
77,625,833  
Filed 2022-08-22 07:52
 
Tx date 2022-08-19
$DMT 
Small Pharma Inc. (formerly, Unilock Capital Corp.)
Rands, Peter David
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$487.50 
+2,500 vol 
$0.195 each
77,589,333

<< Previous
Bullboard Posts
Next >>